Citi Maintains a 'Neutral' on Regeneron Pharma (REGN); Doctors Consider Eylea as Replacement for Roche's Lucentis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. BILL
4. ADI
5. MRK
6. MRNA
7. LOW
8. TJX
9. DE
10. JKHY

Go back to Citi Maintains a 'Neutral' on Regeneron Pharma (REGN); Doctors Consider Eylea as Replacement for Roche's Lucentis
Regeneron (NASDAQ: REGN) Delayed: 835.59 -5.25 (0.62%)
Previous Close $840.84    52 Week High $592.36 
Open $831.70    52 Week Low $325.35 
Day High $837.27    P/E 219.31 
Day Low $830.56    EPS $3.81 
Volume 22,565       

Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 57.85 -0.35 (0.6%)
Previous Close $58.20    52 Week High $35.13 
Open $57.94    52 Week Low $28.10 
Day High $58.04    P/E N/A 
Day Low $57.85    EPS $0.00 
Volume 14,671